Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

29 questions · 29 findings · 2 reviews · Airways

No studies found 13 · 44.8%GRADE not reported 0 · 0%Very low 0 · 0%Low 9 · 31%Moderate 7 · 24.1%High 0 · 0%

Erdosteine vs no treatment

FEV1 · people with bronchiectasis

Erdosteine may leads to higher lung function change in FEV1 (L) at day 15 compared with no treatment (low certainty).

1 finding from 1 review

Bromhexine vs placebo

Adverse events · people with bronchiectasis

Bromhexine showed no clear difference in adverse events compared with placebo (low certainty).

1 finding from 1 review

Bromhexine vs placebo

Health‐related quality of life · people with bronchiectasis

The review found no eligible studies for this question.

1 finding from 1 review

Bromhexine vs placebo

Symptoms difficulty in expectoration · people with bronchiectasis

Bromhexine showed no clear difference in symptoms difficulty in expectoration compared with placebo (low certainty).

1 finding from 1 review

Bromhexine vs placebo

Deaths · people with bronchiectasis

The review found no eligible studies for this question.

1 finding from 1 review

Bromhexine vs placebo

Lung function (FEV₁) · people with bronchiectasis

Bromhexine showed no clear difference in lung function FEV1 compared with placebo (low certainty).

1 finding from 1 review

RhDNase vs placebo

Frequency and duration of exacerbations · people with bronchiectasis

The review found no eligible studies for this question.

1 finding from 1 review

RhDNase vs placebo

Hospitalisations for infective exacerbations · people with bronchiectasis

RhDNase showed no clear difference in hospitalisations for infective exacerbations compared with placebo (low certainty).

1 finding from 1 review